In an analysis of more than 3,100 older adults, low-dose aspirin administered for 3 years did not affect the incidence or progression of age-related macular degeneration, according to study results published in JAMA Ophthalmology.
“We hoped to prove that there is an accessible, cheap and effective method of either prevention or slowing down progression of AMD,” Liubov “Luba” Robman, MBBS, PhD, a senior research fellow in the department of epidemiology and preventive medicine at Monash University in Melbourne, told Healio. “To our disappointment, we discovered that